Table 45-3 Clinical trials of combination strategies in unipolar depression
| Table 45-3 Clinical trials of combination strategies in unipolar depression | |||||
| Investigators | N | Design | Failed trial | Daily dosage | Response rate |
| MAOI+TCA | |||||
| Sethna 1974 | 12 | Open | TCA, MAOI | 75 mg amitriptyline; 45 mg phenelzine | 83% |
| Davidson et al. 1978 | 17 | RCT | Adequate trial with conventional treatments | 20-100 mg amitriptyline; 15-45 mg phenelzine | Combination less effective than ECT |
| Riise and Holm 1984 | 27 | Open | MAOI or TCA alone | 0.5 mg/kg isocarboxazid; 30-90 mgmianserin | 74% |
| Feigner et al. 1985 | 11 | Retrospective | 2-year history of MAOI and TCA treatment resistance | 5-15 mg MAOI; 15-400 mg TCA | 64% |
| Schmauss et al. 1988 | 94 | Retrospective | Two or more trials of TCA or tetracyclic antidepressant | 10-30 mg tranylcypromine; 50-300 mg TCA | 68% |
| SSRI+TCA | |||||
Weilburg et al. 1989 | 30 | Retrospective | Non-MAOI | 20-60 mg fluoxetine; 37.5-400 mg TCA | 87% |
Weilburg et al. 1991 | 20 | Retrospective | Fluoxetine alone | 20-40 mg fluoxetine; 10-100 mg TCA | 65% |
M. Fava et al. 1994b | 41 | RCT | Fluoxetine alone | 20 mg fluoxetine plus 25-50 mg desipramine vs. 40-60 mg fluoxetine | Combination less effective than raising dose |
Levitt et al. 1999 | 13 | Open | Fluoxetine and desipramine or imipramine | 20 mg fluoxetine; 1 mg/kg desipramine orimipramine | 31% |
Note. MAOI = monoamine oxidase inhibitor; TCA = tricyclic antidepressant; RCT = randomized clinical trial; ECT = electroconvulsive therapy; SSRI = selective serotonin reuptake inhibitor. | |||||